Table 1 Patient characteristics
Variables | Total cohort | Matched cohort | ||||
|---|---|---|---|---|---|---|
PDM (n = 32) | Non-PDM (n = 813) | P | PDM (n = 27) | Non-PDM (n = 105) | p | |
Age | 0.839 | 1.000 | ||||
≥ 60 | 15 (46.9%) | 396 (48.7%) | 10 (37.0%) | 40(38.1%) | ||
< 60 | 17 (53.1%) | 417 (51.3%) | 17(63.0%) | 65(61.9%) | ||
Gender | 0.117 | 0.748 | ||||
Male | 24 (76.0%) | 498 (61.3%) | 19(70.4%) | 68(64.8%) | ||
Female | 8 (24.0%) | 315 (38.7%) | 8(29.6%) | 37(35.2%) | ||
BMI (kg/m2) | 0.820 | 0.811 | ||||
≥ 25 | 32 (40.6%) | 314 (38.6%) | 10 (37.0%) | 44(41.9) | ||
< 25 | 19 (59.4%) | 499 (61.4%) | 17(63.0%) | 61(58.1) | ||
ASA score | 0.822 | 0.988 | ||||
I/II | 28 (84.0%) | 700 (86.1%) | 23(85.2) | 92(87.6) | ||
III | 4 (16.0%) | 113 (13.9%) | 4(14.8) | 13(12.4) | ||
Tumor location | 0.011 | 0.936 | ||||
Rb | 12 (32.0) | 137 (16.9) | 7(25.9) | 30(28.6) | ||
Ra | 9 (32.0) | 309(38.0) | 9(33.3) | 36(34.3) | ||
Rs | 11(36.0) | 367 (45.1) | 11(40.7) | 39(37.1) | ||
pTNM | 0.804 | 0.936 | ||||
I | 9 (28.0%) | 194 (23.9%) | 8(29.6) | 34(32.4) | ||
II | 10 (40.0%) | 235 (28.9%) | 7(25.9) | 29(27.6) | ||
III | 12 (28.0%) | 347 (42.7%) | 11(40.7) | 40(38.1) | ||
IV | 1 (4.0%) | 37 (4.5%) | 1(3.7) | 2(1.9) | ||
CEA | 0.688 | 0.390 | ||||
≥ 5 ng/L | 9 (28.1%) | 256 (31.5%) | 7(25.9) | 18(18.8) | ||
< 5 ng/L | 23 (71.9%) | 557 (68.5%) | 20(74.1) | 78(81.2) | ||
nCRT | 5 (8.0%) | 122 (15.0%) | 0.923 | 5(18.5) | 18(17.1) | 1.000 |
LCA retention | 14(43.8) | 104(12.8) | 0.001 | 9(33.3) | 32(30.5) | 0.958 |
ICG | ||||||